News Aug 10, 2021 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...
News Nov 03, 2021 USD 17.5 million for Aktiia’s 24/7 blood pressure monitor Neuchâtel-based health tech start-up Aktiia raised USD 17.5 million in a Series A funding round led by Draper Esprit.
News Jan 20, 2021 The University of Bern equips emergency medicine for the future With the support of the Touring Club Switzerland, an endowed professorship in emergency telemedicine was appointed at the University of Bern, aim...
News Apr 30, 2021 ADC Therapeutics receives FDA approval for its lymphoma cancer treatment ZYNLONTA Oncology biotechnology company ADC Therapeutics has received the first FDA approval for ZYNLONTA, its lead drug candidate for the treatment of ad...
Press Release Jan 11, 2021 Swiss start-ups at CES 2021 Switzerland will be participating in the Consumer Electronics Show (CES) for the third time in a row. From January 11-14, 2021, Switzerland Globa...
Actualités Jan 20, 2021 L’Université de Berne prépare l’avenir de la médecine d’urgence Avec le soutien du Touring Club Suisse, une chaire dotée en télémédecine d'urgence a été créée à l'Université de Berne, visant à offrir un cadre ...
Third Party Event Digitally delivered // BioTrinity 2020 Digitally delivered Greater London United Kingdom
News Mar 08, 2021 The Lausanne University Hospital still ranks among the ten best hospitals worldwide in 2021 After an especially challenging year 2020 for hospitals, the prestigious U.S. magazine Newsweek has once again included the Lausanne University H...